| Trial ID: | L5953 |
| Source ID: | NCT05629806
|
| Associated Drug: |
Metformin Plus Pioglitazone
|
| Title: |
Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Blood Glucose Fluctuation
|
| Interventions: |
DRUG: Metformin plus pioglitazone|DRUG: Acarbose
|
| Outcome Measures: |
Primary: Blood glucose fluctuation, change from baseline blood glucsoe fluctuation at end of study, week 24 |
|
| Sponsor/Collaborators: |
Sponsor: Nanjing First Hospital, Nanjing Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2022-04-10
|
| Completion Date: |
2023-05-31
|
| Results First Posted: |
|
| Last Update Posted: |
2022-11-29
|
| Locations: |
Nanjing First Hospital, Nanjing Medical Univesity, Nanjing, China
|
| URL: |
https://clinicaltrials.gov/show/NCT05629806
|
